| Donor bone marrow–derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice RC Adams, D Carter-Cusack, SN Shaikh, GT Llanes, RL Johnston, ... Blood, The Journal of the American Society of Hematology 139 (9), 1389-1408, 2022 | 18 | 2022 |
| CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice RC Adams, D Carter-Cusack, GT Llanes, CR Hunter, JM Vinnakota, ... Blood 143 (10), 912-929, 2024 | 1 | 2024 |
| Intraperitoneal transfer of wild‐type bone marrow repopulates tissue macrophages in the Csf1r knockout rat without contributing to monocytopoiesis A Sehgal, D Carter‐Cusack, S Keshvari, O Patkar, S Huang, KM Summers, ... European Journal of Immunology 53 (8), 2250312, 2023 | 1 | 2023 |
| The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease CL O’Brien, KM Summers, NM Martin, D Carter-Cusack, Y Yang, R Barua, ... Human Genetics, 1-29, 2024 | | 2024 |
| Genetic and Immunohistochemistry Tools to Visualize Rat Macrophages In Situ S Huang, D Carter-Cusack, E Maxwell, OL Patkar, KM Irvine, DA Hume Tissue-Resident Macrophages: Methods and Protocols, 99-115, 2023 | | 2023 |
| The potential of Senicapoc, a KCNN4 inhibitor, for the prevention and treatment of breast cancer C Xiao, M Miranda, W Shi, J Beesley, JM Saunus, A Civitarese, DM Black, ... bioRxiv, 2023.04. 25.538345, 2023 | | 2023 |
kelli macdonaldQueensland Institute of Medical ResearchVerified email at qimr.edu.au
